Soley Therapeutics and the $200 Million Case for Watching Cells

A cardiologist and a cancer biologist found a shared puzzle in cells under stress. Soley Therapeutics is turning that puzzle into a drug pipeline - and a test of how much a living cell can tell us before a medicine reaches a patient.